COMPOSITION FOR TREATMENT AND METASTASIS INHIBITION OF PANCERATIC CANCER INCLUDING CTHRC1 EXPRESSION AND ACTIVATION INHIBITOR AS AN ACTIVE INGREDIENT
The present invention relates to a protein marker for diagnosing and screening pancreatic cancer and a use thereof. More specifically, it is confirmed that mRNA and protein expressions of CTHRC1 are increased in a sample from a pancreatic cancer patient and the cancer incidence and metastasis are in...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
22.12.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!